|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
3/2011
vol. 113 abstract:
Original paper
Malherbe’s calcifying epithelioma (pilomatrixoma) – own experience
Ewa Czerniawska
1
,
Arkadiusz Pogrzebielski
1
,
Bożena Romanowska-Dixon
1
,
Jolanta Orłowska-Heitzman
2
Klinika Oczna 2011, 113 (3): 237-242
Online publish date: 2011/10/01
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction
Purpose: Malherbe’s calcifying epithelioma is a rare hair matrix tumor. The objective is to present clinical cases and to analyze the variability of its image. Material and methods Among nearly 3500 patients with ocular tumors operated during the last 10 years in the Department of Ophthalmology and Ocular Oncology in Krakow we identified a group of 7 patients with histologically confirmed pilomatrixoma. A retrospective evaluation of their medical history was performed, paying particular attention to the co-existence of other diseases, form of growth and location of tumors, as well as treatment methods and their effectiveness. The results were compared with other clinical studies. Results Malherbe’s calcifying epithelioma is characterized by clinical polymorphism and similarity to other much more frequent eyelid tumors. It usually has the form of a single, small, movable, slowly growing nodule covered by intact skin. In addition to the classic form described there are pediculated tumors, huge, fast-growing, perforating, as well as tumors in unusual locations and multiple lesions. Conclusions The consequences of variation pilomatrixoma are clinical diagnostic errors. The one, sure and reliable criterion is a histopathology evaluation. keywords:
Malherbe’s calcifying epithelioma, pilomatrixoma, eyelid tumors, periorbital tumors |
|
POLSKI
